- Home
- BCRX vs WINA Comparison
BCRX vs WINA Comparison
Compare BCRX & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- WINA
- Stock Information
- Founded
- BCRX 1986
- WINA 1988
- Country
- BCRX United States
- WINA United States
- Employees
- BCRX N/A
- WINA N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- WINA Other Specialty Stores
- Sector
- BCRX Health Care
- WINA Consumer Discretionary
- Exchange
- BCRX Nasdaq
- WINA Nasdaq
- Market Cap
- BCRX 1.7B
- WINA 1.5B
- IPO Year
- BCRX 1994
- WINA 1993
- Fundamental
- Price
- BCRX $9.19
- WINA $379.28
- Analyst Decision
- BCRX Buy
- WINA
- Analyst Count
- BCRX 9
- WINA 0
- Target Price
- BCRX $16.89
- WINA N/A
- AVG Volume (30 Days)
- BCRX 3.6M
- WINA 376.4K
- Earning Date
- BCRX 08-04-2025
- WINA 07-16-2025
- Dividend Yield
- BCRX N/A
- WINA 2.96%
- EPS Growth
- BCRX N/A
- WINA 2.14
- EPS
- BCRX N/A
- WINA 11.19
- Revenue
- BCRX $503,485,000.00
- WINA $83,099,300.00
- Revenue This Year
- BCRX $39.04
- WINA $6.56
- Revenue Next Year
- BCRX $13.26
- WINA $3.57
- P/E Ratio
- BCRX N/A
- WINA $33.51
- Revenue Growth
- BCRX 41.67
- WINA 0.33
- 52 Week Low
- BCRX $6.02
- WINA $295.79
- 52 Week High
- BCRX $11.31
- WINA $459.93
- Technical
- Relative Strength Index (RSI)
- BCRX 34.12
- WINA 31.96
- Support Level
- BCRX $9.19
- WINA $369.01
- Resistance Level
- BCRX $10.07
- WINA $459.93
- Average True Range (ATR)
- BCRX 0.34
- WINA 20.00
- MACD
- BCRX -0.18
- WINA -9.50
- Stochastic Oscillator
- BCRX 8.10
- WINA 0.00
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About WINA Winmark Corporation
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.